Compare ARLP & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARLP | ICUI |
|---|---|---|
| Founded | 1971 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.9B |
| IPO Year | 1999 | 1995 |
| Metric | ARLP | ICUI |
|---|---|---|
| Price | $28.88 | $127.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $29.50 | ★ $182.25 |
| AVG Volume (30 Days) | ★ 319.4K | 237.4K |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 8.39% | N/A |
| EPS Growth | N/A | ★ 100.62 |
| EPS | N/A | ★ 0.03 |
| Revenue | $2,002,857,000.00 | ★ $2,231,262,000.00 |
| Revenue This Year | $3.84 | N/A |
| Revenue Next Year | $3.73 | $4.46 |
| P/E Ratio | ★ $10.68 | $4,379.00 |
| Revenue Growth | ★ 11.50 | N/A |
| 52 Week Low | $22.41 | $107.02 |
| 52 Week High | $28.95 | $160.29 |
| Indicator | ARLP | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 69.11 | 39.89 |
| Support Level | $25.31 | $122.17 |
| Resistance Level | N/A | $136.39 |
| Average True Range (ATR) | 0.69 | 5.06 |
| MACD | 0.07 | 0.37 |
| Stochastic Oscillator | 90.43 | 42.84 |
Alliance Resource Partners LP operates as a coal mining company based in the United States. It has four segments: Illinois Basin, Appalachia, Oil & Gas Royalties, and Coal Royalties. The Illinois Basin comprises underground mining complexes in Illinois, Indiana, Kentucky, Maryland, and West Virginia. The Appalachia segment comprises the Mettiki mining complex, the Tunnel Ridge mining complex, and the MC Mining complex. The Oil & Gas Royalties has oil & gas mineral interests held by AR Midland and AllDale I & II, and includes Alliance Minerals' equity interests in both AllDale III and Cavalier Minerals. The Coal Royalties have included coal mineral reserves and resources owned or leased by Alliance Resource Properties.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.